Kochin Israel N, Miloh Tamir A, Arnon Ronen, Iyer Kishore R, Suchy Frederick J, Kerkar Nanda
Pediatric Hepatology, Division of Pediatric Hepatology and RMTI, Department of Surgery, Mount Sinai School of Medicine, New York City, NY 10029, USA.
Isr Med Assoc J. 2011 Sep;13(9):542-7.
Primary liver masses in children may require intervention because of symptoms or concern about malignant transformation.
To review the management and outcome of benign liver masses in children.
We conducted a retrospective chart review of children with liver masses referred to our institution during the period 1997-2009.
Benign liver masses were identified in 53 children. Sixteen of these children (30%) had hemangioma/infantile hepatic hemangioendothelioma (IHH) and 15 (28%) had focal nodular hyperplasia. The remainder had 6 cysts, 4 hamartomas, 3 nodular regenerative hyperplasia, 2 adenomas, 2 vascular malformations, and one each of polyarteritis nodosa, granuloma, hepatic hematoma, lymphangioma, and infarction. Median age at presentation was 6 years, and 30 (57%) were female. Masses were initially noticed on imaging studies performed for unrelated symptoms in 33 children (62%), laboratory abnormalities consistent with liver disease in 11 (21%), and palpable abdominal masses in 9 (17%). Diagnosis was made based on characteristic radiographic findings in 31 (58%), but histopathological examination was required for the remaining 22 (42%). Of the 53 children, 27 (51%) were under observation while 17 (32%) had masses resected. Medications targeting masses were used in 9 (17%) and liver transplantation was performed in 4 (8%). The only death (2%) occurred in a child with multifocal IHH unresponsive to medical management and prior to liver transplant availability.
IHH and focal nodular hyperplasia were the most common lesions. The majority of benign lesions were found incidentally and diagnosed radiologically. Expectant management was sufficient in most children after diagnosis, although surgical intervention including liver transplant was occasionally necessary.
儿童原发性肝脏肿块可能因症状或对恶变的担忧而需要干预。
回顾儿童良性肝脏肿块的管理及结局。
我们对1997年至2009年期间转诊至我院的肝脏肿块患儿进行了回顾性病历审查。
53例儿童被确诊为良性肝脏肿块。其中16例(30%)患有血管瘤/婴儿型肝血管内皮瘤(IHH),15例(28%)患有局灶性结节性增生。其余患儿分别患有6例囊肿、4例错构瘤、3例结节性再生性增生、2例腺瘤、2例血管畸形,以及各1例结节性多动脉炎、肉芽肿、肝血肿、淋巴管瘤和梗死。就诊时的中位年龄为6岁,30例(57%)为女性。33例(62%)患儿最初是在因无关症状进行的影像学检查中发现肿块,11例(21%)因与肝病相符的实验室异常发现肿块,9例(17%)因可触及腹部肿块发现肿块。31例(58%)患儿根据特征性影像学表现确诊,但其余22例(42%)需要组织病理学检查确诊。53例患儿中,27例(51%)接受观察,17例(32%)接受了肿块切除术。9例(17%)使用了针对肿块的药物治疗,4例(8%)接受了肝移植。唯一1例死亡(2%)发生在1例患有多灶性IHH且药物治疗无效且未获得肝移植的患儿。
IHH和局灶性结节性增生是最常见的病变。大多数良性病变是偶然发现并通过影像学诊断的。诊断后,大多数患儿进行观察即可,但偶尔需要包括肝移植在内的手术干预。